Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
424studies shown
Showing 205-216 of 424
Behavioral study icon
RecruitingNCT06118268

iTBS to Enhance Social Cognition in People With Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Glen Oaks
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 39 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT07225179

mHealth for Early Psychosis Caregivers in Statewide Program Outreach

This summary needs review. Please check the official study record and contact the research team for details.

In Chapel Hill
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralOver 18 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT05457140

Multiomic Diagnostics in Youth With Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In San Diego
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 7 Years to 17 Years
Countries
United States
Sponsor
Rady Pediatric Genomics & Systems Medicine Institute
Condition
Schizophrenia
Device study icon
RecruitingNCT04368039

Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Columbus
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 15 Years to 35 Years
Countries
United States
Sponsor
Nicholas Breitborde
Condition
Schizophrenia
Drug study icon
RecruitingNCT03971487

Ocrelizumab for Psychosis by Autoimmunity

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 35 Years
Countries
United States
Sponsor
The Methodist Hospital Research Institute
Condition
Schizophrenia
Drug study icon
RecruitingNCT07029581

ACP-204 for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Bulgaria, ...

Multiple locations, including Irvine
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 84 Years
Countries
United States, France, Bulgaria, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
RecruitingNCT04373317

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Loma Linda
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 40 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
Other study type icon
RecruitingNCT07459270

Psychiatric Symptom Characteristics in Methamphetamine-Induced Psychosis With and Without Lifetime Cannabis Use

This summary needs review. Please check the official study record and contact the research team for details.

In Elâzığ
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Türkiye
Sponsor
Elazığ Mental Health and Diseases Hospital
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.